Source · GIRFT National Specialty Report

Pancreatic Cancer

GIRFT Programme National Specialty Report on pancreatic cancer. Recommendations are taken from the published executive summary; the full report is on FutureNHS, which requires a login.

Published 1 November 2025 Pancreatic Cancer Lead: Raneem Albazaz, Daniel Palmer, Claire Pearce, Ganesh Radhakrishna and Keith Roberts

View on GIRFT ↗  ·  Download Report PDF ↗

Indexed content

12 recommendations 11 addressees 1 of 12 linked to a body

Recommendations

12 total
Recommendation 1 Addressee: Specialist multidisciplinary teams (sMDTs)
Specialist multidisciplinary teams (sMDTs) should have effective channels of communication in place with spokes to ensure cohesive, coherent and collaborative care for all patients.
Recommendation 2 Addressee: sMDTs
sMDTs should streamline meetings and optimise processes to prevent delays, promote cost-effectiveness and focus discussions on appropriate patients.
Recommendation 3 Addressee: Trusts
Trusts should prioritise fast track pancreatic cancer diagnosis and treatment.
Recommendation 4 Addressee: Trusts
Trusts should implement the NHS England Best Practice Timed Pathway for HPB cancers.
Recommendation 5 Addressee: HPB radiologists within sMDTs
HPB radiologists within sMDTs should adopt the PACT-UK radiology reporting template to standardise and improve treatment decision making.
Recommendation 6 Addressee: Cancer Alliance
Cancer alliances should consider adopting a single-queue approach to diagnostic procedures such as EUS/ERCP, to pool waiting lists between organisations.
Full addressee: Cancer alliances
Recommendation 7 Addressee: Surgical centres
Surgical centres should adopt a stepwise approach to improving resection rates, including rates of borderline resectable and locally advanced disease surgery and neoadjuvant therapy, and upskill the surgical team to deliver such surgery.
Recommendation 8 Addressee: Specialist multidisciplinary teams; oncology centres; cancer alliances
Specialist multidisciplinary teams, oncology centres and cancer alliances should improve patient access to expert HPB clinical and medical oncological opinions and treatment and harness the benefit of centralised expertise and experience. (HPB oncology is recognised as a distinct subspeciality).
Recommendation 9 Addressee: Providers
Providers should ensure they have a safe and efficient CNS service to support each pancreatic cancer patient on diagnosis and follow-up.
Recommendation 10 Addressee: Trusts/HPB teams
Trusts/HPB teams should prioritise pancreatic management strategies to improve all pancreatic cancer patients’ quality of life.
Recommendation 11 Addressee: Trusts; ICBs; cancer alliances
Trusts, ICBs and cancer alliances should ensure that all cancer centres have equitable and timely access to enhanced supportive care or a supportive oncology service, with all pancreatic cancer patients referred at diagnosis.
Recommendation 12 Addressee: Trusts; sMDTs
Trusts and sMDTs to improve data collection and coding using NHS England and GIRFT guidance for clinical coders where available.